Oncology

In a groundbreaking study evaluating intraoperative radiotherapy (IORT) as a tumor bed boost with whole-breast irradiation (WBI) for patients with breast cancer undergoing breast-conserving surgery (BCS), researchers found that the combination approach offers promising safety and efficacy outcomes.

A pilot study using indocyanine green lymphography (ICG-L) has provided new insight into how head and neck cancer (HNC) treatments disrupt lymphatic drainage and contribute to lymphoedema, highlighting an often-overlooked source of physical and neurological symptom burden among survivors.

A new survey reveals that nearly half of patients receiving radiation therapy for cancer are open to exploring psychedelic-assisted therapy, spotlighting a growing curiosity about novel approaches to managing cancer-related distress.

Anal cancer screening in people with HIV (PWH) is entering a new era, following major advances in evidence and recent guideline updates that aim to reduce cancer burden in this high-risk group.

Immune checkpoint inhibitors (ICIs) have transformed cancer care but can trigger immune-related adverse events such as psoriasis, complicating treatment decisions.

A novel deep learning approach to body composition analysis may offer a cost-effective and clinically relevant method to predict treatment outcomes in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), according to findings from the LOTIS-2 trial.

The use of beta-blockers has dramatically changed the management of infantile hemangiomas, with a significant increase in active treatment decisions at tertiary referral centers, according to a new retrospective cohort study.

Subcutaneous (SC) delivery of immunotherapies for solid tumors has emerged as a potentially transformative approach to cancer treatment, promising comparable clinical efficacy to intravenous (IV) therapies while significantly reducing treatment time and burden on healthcare systems.